Jeremy D. Jokinen

AbbVie (United States) · Bristol-Myers Squibb (United States) · University of Illinois Chicago

4本站收录论文

32这些论文的被引

3本站 h 指数

12合作者

作者编号 A5021614525 · ORCID 0000-0001-8484-5788。统计只算本站收录的论文。

发表的论文4 篇，按出版时间

1
Behavioral Science: Enhancing Our Approach to the Development of Effective Additional Risk Minimization StrategiesDrug Safety20243
2
Impact of adverse event reports from marketing authorization holder-sponsored patient support programs on the performance of signal detection in pharmacovigilanceExpert Opinion on Drug Safety20206
3
Pooling Different Safety Data Sources: Impact of Combining Solicited and Spontaneous Reports on Signal Detection In PharmacovigilanceDrug Safety201917
4
The future of safety science is happening now: The modernization of the benefit‐risk paradigmPharmacoepidemiology and Drug Safety20176

按月发文

逐年被引

合作者

Elaine H. Morrato1 篇 Todd A. Lee1 篇 Joanne Treacy1 篇 Robert Horne1 篇 Michael Wolf1 篇 Ameet Bakhai1 篇 Marie-Claire Wilson1 篇 Mark Lightowler1 篇 Sibel Guerler1 篇 Fabio A. Lievano1 篇 Linda J. Scarazzini1 篇 Rosalind J. Walley1 篇

研究主题和期刊

Drug Safety2 Pharmacoepidemiology and Drug Safety1 Expert Opinion on Drug Safety1